Animal Pharm is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Joseph Harvey

London
As Editor of Animal Pharm, Joseph Harvey provides news and analysis about the global animal health market across a range of species and products. He conducts exclusive interviews with the sector's biggest companies and experts, as well as start-up firms. He also hosts webinars and gives speeches on the industry.

Having gained many years' experience in business journalism, Joseph joined Informa in 2007, reporting on the medical technology space. He joined Animal Pharm, rising to become editor and taking the publication online only.

Joseph also launched a series of well-received webinars. As author of a top-selling industry report, he detailed the leading companies in the animal health sector. Since becoming editor, he has transformed Animal Pharm from just a news provider into a more in-depth analytical service.
Advertisement
Set Alert for Articles By Joseph Harvey

Latest From Joseph Harvey

Virbac to replicate third-party product model in China through partnerships

Virbac's top priority in China is to establish partnerships to sell products through third-party collaborations.

China Virbac

Pebble Labs developing 'transbiotics' gene silencing tech for shrimp diseases

Pebble Labs aims to introduce the concept of 'transbiotics' to the animal health industry, with shrimp as its first target.

Aquaculture R&D

Tiba offers programmable RNA vaccine platform to animal health partners

US-based Tiba Biotech has developed a platform technology for the rapid production of self-replicating mRNA vaccines that can be programed to protect against multiple pathogens.

R&D Vaccines

Stonehaven Incubate supports crossover work with first fundraising

A group of global life science and animal health investors have invested in Stonehaven Incubate, which aims to support the creation of young animal health companies.

Investments R&D

KindredBio ahead of competitors with IL-31, mulling enquires

Kindred Biosciences believes it is ahead of competitors in developing its interleukin-31 (IL-31) antibody.

Kindred Biosciences R&D

Pulike strategy looks to sustainable long-term growth

Chinese firm Pulike Biological Engineering is building a stronger platform for long-term sales growth.

China Vaccines
See All
Advertisement
UsernamePublicRestriction

Register